RxDoctor Payments DataLook up a doctor →

Barry Gruber, MD

Rheumatology · Babylon, NYNPI 1710912431

Payments from drug & device makers

$922,674in general payments, 2019–2025

Across 1,966 payments — averaging $469.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$613K
  • Radius Health, Inc.$76K
  • Boehringer Ingelheim$42K
  • Pacira Therapeutics, Inc.$32K
  • AbbVie$29K
  • United Rheumatology$29K
  • plus $101K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)877$613,471
Radius Health, Inc.112$76,106
Boehringer Ingelheim73$42,139
Pacira Therapeutics, Inc.38$31,993
AbbVie150$29,021
United Rheumatology5$28,798
E.r. Squibb & Sons, L.L.C.55$26,501
Regeneron Healthcare Solutions, Inc.28$14,774
Mallinckrodt Enterprises LLC26$10,483
Bristol Myers Squibb15$10,374
Kyowa Kirin, Inc.19$7,865
Sanofi9$6,502
Johnson & Johnson(3 entities)138$5,023
Janssen Scientific Affairs, LLC8$4,344
Sobi, Inc7$2,877
Mallinckrodt Hospital Products Inc.10$1,934
Fresenius Kabi USA, LLC5$1,638
UCB, Inc.76$1,637
Pfizer66$1,132
Aurinia Pharma U.S., Inc.14$835
Lilly USA, LLC35$698
Novartis33$563
Genentech USA, Inc.29$538
ANI Pharmaceuticals, Inc.23$519
AstraZeneca(2 entities)21$483
GSK19$412
Biohaven Pharmaceutical Holding Company Ltd.6$319
Organon10$285
Medexus Pharma, Inc.6$146
Ferring Pharmaceuticals Inc.7$139
Merck9$131
Sanofi-aventis U.S. LLC1$130
Actelion Pharmaceuticals US, Inc.3$117
Zimmer Biomet3$85
Kiniksa Pharmaceuticals International, PLC3$77
Almatica Pharma LLC3$67
Hikma Pharmaceuticals USA3$65
Vertex2$61
Ultragenyx Pharmaceutical Inc.3$55
Pacira Pharmaceuticals Incorporated2$49
Antares Pharma, Inc.2$46
Sandoz2$39
Takeda Pharmaceuticals U.S.A., Inc.2$30
Kiniksa Pharmaceuticals, Ltd.1$29
Bioxcel Therapeutics, Inc.1$28
Bioventus LLC1$26
Alvogen Inc1$25
Teva Pharmaceuticals USA, Inc.1$20
Scilex Pharmaceuticals Inc.1$19
Kowa Pharmaceuticals America, Inc.1$16
Shire North American Group Inc1$13

How this compares

$922,674 in reported general payments places this provider in the 95th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York →

Medicare billing

Part B allowed, 2024
$3,430,824
Medicare patients
1,095
Services billed
193,756

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Babylon

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →